• 6993 Citations
  • 42 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Adrian Vella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Glucose Medicine & Life Sciences
Type 2 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Glucagon-Like Peptide 1 Medicine & Life Sciences
Type 1 Diabetes Mellitus Medicine & Life Sciences
Gastric Emptying Medicine & Life Sciences
Gastric Bypass Medicine & Life Sciences
Meals Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2007 2017

Bariatric Surgery
Carbohydrate Metabolism
Glucose
Intestinal Secretions
Insulin
Glucose
Insulin
Type 2 Diabetes Mellitus
Prediabetic State
Proglucagon

Research Output 1996 2019

Assessment of pulsatile insulin secretion derived from peripheral plasma C-peptide concentrations by nonparametric stochastic deconvolution

Laurenti, M. C., Vella, A., Varghese, R. T., Andrews, J. C., Sharma, A., Kittah, N. E., Rizza, R. A., Matveyenko, A. V., De Nicolao, G., Cobelli, C. & Dalla Man, C., May 1 2019, In : American journal of physiology. Endocrinology and metabolism. 316, 5, p. E687-E694

Research output: Contribution to journalArticle

C-Peptide
Insulin
Hepatic Veins
Type 2 Diabetes Mellitus
Liver
1 Citation (Scopus)

Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB)

Shah, M., Laurenti, M. C., Dalla Man, C., Ma, J., Cobelli, C., Rizza, R. A. & Vella, A., Apr 1 2019, In : Metabolism: Clinical and Experimental. 93, p. 10-17 8 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide 1
Gastric Bypass
Type 2 Diabetes Mellitus
Glucose
Insulin

Letter to the Editor: "Defects in GLP-1 Response to an Oral Challenge Do Not Play a Significant Role in the Pathogenesis of Prediabetes"

Smushkin, G., Sathananthan, A., Man, C. D., Camilleri, M., Cobelli, C., Rizza, R. A. & Vella, A., Nov 1 2019, In : The Journal of clinical endocrinology and metabolism. 104, 11, p. 5106-5107 2 p.

Research output: Contribution to journalArticle

Prediabetic State
Glucagon-Like Peptide 1
Defects
2 Citations (Scopus)

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator

Vella, A., Freeman, J. L. R., Dunn, I., Keller, K., Buse, J. B. & Valcarce, C., Jan 16 2019, In : Science Translational Medicine. 11, 475, eaau3441.

Research output: Contribution to journalArticle

Glucokinase
Hypoglycemia
Liver
Type 2 Diabetes Mellitus
Placebos